Atlas Trials

Neurotransmitter Agents

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neurotransmitter Agents

RecordFirmDate
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU) (NCT07210463)Merz Aesthetics GmbH2025-10-01
Efficacy of Satisens® in Reducing Emotional Eating (NCT07079046)José Enrique de la Rubia Ortí, Ph2025-09-15
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in the United States (NCT07122193)Merz North America, Inc.2025-08-27
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression (NCT06511908)National Institute of Mental Health (NIMH)2024-11-06
Nebulized Ketamine for the Treatment of Major Depressive Disorder (NCT06752759)Theresa Jacob, PhD, MPH2024-10-16
Natural History of Depression, Bipolar Disorder and Suicide Risk (NCT06462196)National Institute of Mental Health (NIMH)2024-09-09
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression (NCT05615948)Theresa Jacob, PhD, MPH2022-12-06
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder (NCT05321602)Luye Pharma Group Ltd.2021-09-08
Relative Bioavailability of LY03010 Compared to Listed Drug (NCT04922593)Luye Pharma Group Ltd.2021-01-13
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome (NCT05657860)Maimonides Medical Center2020-12-17
Lidocaine and Magnesium and Ketamine in Gynecological Surgery (NCT04622904)Aretaieion University Hospital2020-11-14

Track Neurotransmitter Agents automatically

Every clearance here is in the API, with alerts when new ones post.